Biosimilar Newsletter Archive

  1. 06.30.21 -- Why Switch From Batch To Multi-Column Chromatography? 6/30/2021

    06/30/21 Biosimilar Development Newsletter

  2. 06.27.21 -- Patenting Antibodies: The 4 Tactics To Use In 2021 6/27/2021
    06/27/21 Biosimilar Development Newsletter
  3. 06.25.21 -- Key Strategies For Intensifying Your Upstream Bioprocesses 6/25/2021

    06/25/21 Biosimilar Development Newsletter

  4. 06.24.21 -- Patenting Antibodies: The 4 Tactics To Use In 2021 6/24/2021
    06/24/21 Biosimilar Development Newsletter
  5. 06.18.21 -- Risk Management In Biologics Combination Product Development 6/18/2021

    06/18/21 Biosimilar Development Newsletter

  6. 06.17.21 -- Outlook: Biotech In 2021 & Beyond 6/17/2021
    06/17/21 Biosimilar Development Newsletter
  7. 06.10.21 -- Latest On Purifying Cryo-EM Samples And Infectious Virus Particles 6/10/2021

    06/10/21 Biosimilar Development Newsletter

  8. 06.10.21 -- Small-Scale Model Qualification For Upstream & Downstream Bioprocessing 6/10/2021
    06/10/21 Biosimilar Development Newsletter
  9. 06.09.21 -- Exosomes' Therapeutic Potential, AAV and Lentiviral Gene Therapies, and more from the Business of Biotech Podcast 6/9/2021
    06/09/21 Biosimilar Development Newsletter
  10. 06.07.21 -- Evolving Biosafety Testing To Meet The Needs Of Biologics Manufacturers 6/7/2021

    06/07/21 Biosimilar Development Newsletter